| scholarly article | Q13442814 |
| P2093 | author name string | Riccardo Olcese | |
| Hrayr S Karagueuzian | |||
| Marina Angelini | |||
| Arash Pezhouman | |||
| P2860 | cites work | [Research on the benzofuran series. XL. Anti-arrhythmic properties of amiodarone]. | Q54376140 |
| Excitation–contraction coupling in human heart failure examined by action potential clamp in rat cardiac myocytes | Q57942389 | ||
| Survival with oral d-Sotalol in patients with left ventricular dysfunction after myocardial infarction: Rationale, design, and methods (the SWORD trial) | Q58011152 | ||
| Effect of 2,3-butanedione 2-monoxime on slow inward and transient outward currents in rat ventricular myocytes | Q64038933 | ||
| Reentrant and focal mechanisms underlying ventricular tachycardia in the human heart | Q67593293 | ||
| The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology | Q67700855 | ||
| Comparative clinical and electrophysiologic effects of adenosine triphosphate and verapamil on paroxysmal reciprocating junctional tachycardia | Q68286211 | ||
| Folate treatment of diphenylhydantoin-induced gingival hyperplasia | Q69644384 | ||
| New selective inhibitors of the transmembrane Ca conductivity in mammalian myocardial fibres. Studies with the voltage clamp technique | Q70374287 | ||
| Electrophysiological effects of diphenylhydantoin on canine purkinje fibers | Q72024388 | ||
| Effects of diphenylhydantoin sodium (dilantin sodium) and phenobarbital sodium upon ectopic ventricular tachycardia in acute myocardial infarction | Q75626810 | ||
| Age-associated alterations in calcium current and its modulation in cardiac myocytes | Q77306755 | ||
| Electrical restitution and spatiotemporal organization during ventricular fibrillation | Q77381420 | ||
| The protective action of various agents against chloroform-epinephrine ventricular fibrillation | Q80304589 | ||
| Antifibrillatory action | Q80318623 | ||
| Contribution of late sodium current (I(Na-L)) to rate adaptation of ventricular repolarization and reverse use-dependence of QT-prolonging agents | Q83027521 | ||
| L-type Ca(2+) channel contributes to alterations in mitochondrial calcium handling in the mdx ventricular myocyte | Q85928310 | ||
| A mutation in CALM1 encoding calmodulin in familial idiopathic ventricular fibrillation in childhood and adolescence | Q86057040 | ||
| A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias | Q87375537 | ||
| PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts | Q22254160 | ||
| Transgenic CaMKIIdeltaC overexpression uniquely alters cardiac myocyte Ca2+ handling: reduced SR Ca2+ load and activated SR Ca2+ release | Q24299281 | ||
| The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure | Q24299296 | ||
| Voltage-gated ion channel dysfunction precedes cardiomyopathy development in the dystrophic heart | Q24306601 | ||
| The effect of amiodarone, a new anti-anginal drug, on cardiac muscle | Q24669966 | ||
| Regulation of CaMKII signaling in cardiovascular disease | Q26785302 | ||
| The role of late I Na in development of cardiac arrhythmias | Q26823149 | ||
| From foe to friend: using animal toxins to investigate ion channel function | Q26864410 | ||
| CaMKII oxidative activation and the pathogenesis of cardiac disease | Q26998988 | ||
| Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias | Q26999872 | ||
| Role of sodium and calcium dysregulation in tachyarrhythmias in sudden cardiac death | Q27339434 | ||
| Treating arrhythmias with adjunctive magnesium: identifying future research directions | Q28078430 | ||
| Perspective: a dynamics-based classification of ventricular arrhythmias | Q28082968 | ||
| The neurobiology of antiepileptic drugs | Q28267900 | ||
| Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial | Q28300531 | ||
| A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation | Q29620430 | ||
| Synchronization of chaotic early afterdepolarizations in the genesis of cardiac arrhythmias | Q30486315 | ||
| Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome | Q30499663 | ||
| Suppression of re-entrant and multifocal ventricular fibrillation by the late sodium current blocker ranolazine | Q30622882 | ||
| Molecular mechanism for an inherited cardiac arrhythmia | Q33173678 | ||
| Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass. | Q33618629 | ||
| Electrophysiology and pharmacology of cardiac arrhythmias. VI. Cardiac effects of verapamil | Q33980593 | ||
| Antiepileptic activity of preferential inhibitors of persistent sodium current | Q34020942 | ||
| So Little Source, So Much Sink: Requirements for Afterdepolarizations to Propagate in Tissue | Q34099038 | ||
| Ventricular fibrillation: how do we stop the waves from breaking? | Q34101077 | ||
| Voltage-gated ion channels and gating modifier toxins. | Q34161355 | ||
| Glycolytic inhibition and calcium overload as consequences of exogenously generated free radicals in rabbit hearts | Q34199804 | ||
| A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474 | Q34234794 | ||
| Pharmacology of amiodarone, and anti-anginal drug with a new biological profile | Q34238807 | ||
| Cellular mechanism of reentry induced by a strong electrical stimulus: implications for fibrillation and defibrillation | Q34239971 | ||
| The effects of the Anemonia sulcata toxin (ATX II) on membrane currents of isolated mammalian myocytes | Q34248545 | ||
| Classifying antiarrhythmic actions: by facts or speculation | Q34292204 | ||
| Treatment of Atrial Fibrillation | Q34486209 | ||
| Cardiac actions in the dog of a new antagonist of adrenergic excitation which does not produce competitive blockade of adrenoceptors | Q35225966 | ||
| Targeting the late component of the cardiac L-type Ca2+ current to suppress early afterdepolarizations | Q35543129 | ||
| Rational strategy to stop arrhythmias: Early afterdepolarizations and L-type Ca2+ current. | Q35642617 | ||
| Chronic heart failure slows late sodium current in human and canine ventricular myocytes: implications for repolarization variability. | Q35741443 | ||
| Glycolytic inhibition causes spontaneous ventricular fibrillation in aged hearts | Q35825880 | ||
| Impaired Inactivation of L-Type Ca2+ Current as a Potential Mechanism for Variable Arrhythmogenic Liability of HERG K+ Channel Blocking Drugs | Q35941355 | ||
| Mechanistic Investigation of the Arrhythmogenic Role of Oxidized CaMKII in the Heart | Q35989578 | ||
| Enhanced sensitivity of aged fibrotic hearts to angiotensin II- and hypokalemia-induced early afterdepolarization-mediated ventricular arrhythmias | Q36042700 | ||
| Sodium channel inactivation: molecular determinants and modulation | Q36267779 | ||
| Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation | Q36331025 | ||
| From pulsus to pulseless: the saga of cardiac alternans | Q36489923 | ||
| Late sodium current in failing heart: friend or foe? | Q36496273 | ||
| Arrhythmogenesis in Timothy Syndrome is associated with defects in Ca(2+)-dependent inactivation | Q36540252 | ||
| Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations. | Q36839147 | ||
| Early afterdepolarizations in cardiac myocytes: beyond reduced repolarization reserve | Q36943422 | ||
| Late sodium current is a new therapeutic target to improve contractility and rhythm in failing heart | Q36954069 | ||
| The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload | Q37114848 | ||
| The role of antiarrhythmic drug therapy for the prevention of sudden cardiac death | Q37161644 | ||
| Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. | Q37170829 | ||
| Drug-induced spatial dispersion of repolarization | Q37225550 | ||
| Increased susceptibility of aged hearts to ventricular fibrillation during oxidative stress | Q37430956 | ||
| Adenosine and supraventricular tachycardia | Q37483560 | ||
| Concept of the vulnerable parameter: the Sicilian Gambit revisited | Q37597854 | ||
| Selective inhibition of late sodium current suppresses ventricular tachycardia and fibrillation in intact rat hearts | Q37658443 | ||
| Cardiac electrophysiology of adenosine. Basic and clinical concepts | Q37706887 | ||
| New drugs vs. old concepts: a fresh look at antiarrhythmics. | Q37855130 | ||
| CaMKII in the cardiovascular system: sensing redox states. | Q37899670 | ||
| Bifurcation theory and cardiac arrhythmias. | Q38086408 | ||
| Inhibition of late sodium current by mexiletine: a novel pharmotherapeutical approach in timothy syndrome | Q38098506 | ||
| Cardiac late Na⁺ current: proarrhythmic effects, roles in long QT syndromes, and pathological relationship to CaMKII and oxidative stress | Q38280608 | ||
| Role of CaMKII in cardiac arrhythmias | Q38313769 | ||
| CaMKII as a target for arrhythmia suppression | Q38981198 | ||
| Modeling Timothy syndrome with iPS cells | Q39214098 | ||
| Bi-stable wave propagation and early afterdepolarization-mediated cardiac arrhythmias. | Q39994023 | ||
| Roscovitine, a cyclin-dependent kinase inhibitor, affects several gating mechanisms to inhibit cardiac L-type (Ca(V)1.2) calcium channels | Q40093407 | ||
| Value of digoxin in heart failure and sinus rhythm: new features of an old drug? | Q41136385 | ||
| Magnesium suppression of early afterdepolarizations and ventricular tachyarrhythmias induced by cesium in dogs | Q41437028 | ||
| Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology | Q41531498 | ||
| Antiarrhythmic drug classification: new science and practical applications | Q41856633 | ||
| Do arrhythmias still deserve our intellectual efforts?: The 2002 Wenckebach Lecture of the Netherlands Society of Cardiology | Q42331965 | ||
| A novel computational model of mouse myocyte electrophysiology to assess the synergy between Na+ loading and CaMKII. | Q42452421 | ||
| Calmodulin mutations associated with long QT syndrome prevent inactivation of cardiac L-type Ca(2+) currents and promote proarrhythmic behavior in ventricular myocytes | Q42551776 | ||
| Oxidative-stress-induced afterdepolarizations and calmodulin kinase II signaling | Q42561090 | ||
| Preferential block of late sodium current in the LQT3 DeltaKPQ mutant by the class I(C) antiarrhythmic flecainide. | Q42616350 | ||
| Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). | Q42874726 | ||
| The aging heart: changes in the pharmacodynamic electrophysiological response to verapamil in aged rabbit hearts. | Q43076907 | ||
| Molecular Basis of Hypokalemia-Induced Ventricular Fibrillation | Q43203951 | ||
| Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy | Q43741617 | ||
| Action potential duration restitution and ventricular fibrillation due to rapid focal excitation | Q43963450 | ||
| Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry | Q45307190 | ||
| Spontaneous atrial fibrillation initiated by triggered activity near the pulmonary veins in aged rats subjected to glycolytic inhibition. | Q46017004 | ||
| Shaping a new Ca²⁺ conductance to suppress early afterdepolarizations in cardiac myocytes. | Q46036586 | ||
| Inhibition of late sodium current attenuates ionic arrhythmia mechanism in ventricular myocytes expressing LaminA-N195K mutation | Q46088940 | ||
| Calcium-sensitive inactivation in the gating of single calcium channels | Q46983735 | ||
| L-type calcium currents of human myocytes from ventricle of non-failing and failing hearts and from atrium | Q50117691 | ||
| Ranolazine safely decreases ventricular and atrial fibrillation in Timothy syndrome (LQT8). | Q50302063 | ||
| Evidence for multiple mechanisms in human ventricular fibrillation. | Q51153144 | ||
| Ionic mechanism of the effects of hydrogen peroxide in rat ventricular myocytes. | Q51543526 | ||
| Origins of spiral wave meander and breakup in a two-dimensional cardiac tissue model. | Q52073136 | ||
| Misplaced brain sodium channels in heart kindle sudden death in epilepsy. | Q52151069 | ||
| The effect of aconitine on the membrane current in cardiac muscle. | Q52757629 | ||
| The management of cardiac arrhythmias during cardiac surgery. | Q52771043 | ||
| Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction. | Q53630608 | ||
| Open state block by fendiline of L-type Ca++ channels in ventricular myocytes from rat heart. | Q53955054 | ||
| Macroreentry in the infarcted human heart: the mechanism of ventricular tachycardias with a "focal" activation pattern. | Q54287213 | ||
| P304 | page(s) | 36 | |
| P577 | publication date | 2017-02-06 | |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | Enhanced Late Na and Ca Currents as Effective Antiarrhythmic Drug Targets | |
| P478 | volume | 8 |
| Q47721428 | Applications of Dynamic Clamp to Cardiac Arrhythmia Research: Role in Drug Target Discovery and Safety Pharmacology Testing. |
| Q58574898 | Atrial Fibrillation Initiated by Early Afterdepolarization-Mediated Triggered Activity during Acute Oxidative Stress: Efficacy of Late Sodium Current Blockade |
| Q90248065 | Calcium Handling Defects and Cardiac Arrhythmia Syndromes |
| Q39360546 | Calcium Signaling and Cardiac Arrhythmias |
| Q92061626 | Dynamic clamping human and rabbit atrial calcium current: narrowing ICaL window abolishes early afterdepolarizations |
| Q39425307 | Investigational antiarrhythmic agents: promising drugs in early clinical development. |
| Q89235554 | Substrates and potential therapeutics of ventricular arrhythmias in heart failure |
| Q93074045 | The molecular determinants of R-roscovitine block of hERG channels |
| Q91964347 | Wanted: Class VI Antiarrhythmic Drug Action; New Start for a Rational Drug Therapy |
Search more.